Biologics

ISPRI Breakthrough Enhances Biologic Therapeutics Development

  In the pursuit of developing novel biologic entities, scientists harnessing the power of AI and generative biology depend on computational to...

 April 02, 2024 | News

Bridge Biotherapeutics Partners with Emory University to Combat Lung Cancer Resistance

 Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, ...

 March 29, 2024 | News

Sanyou Bio: Pioneering the Future of Biologics R&D with Intelligence-Enabled Platform

  Sanyou Biopharmaceuticals emerges as a frontrunner in the biotechnology sector. Under the vision of its founder and CEO, Dr. Guojun Lang, Sanyou Bi...

 March 28, 2024 | Product Spotlight

EditCo Bio Launches with Acquisition of Synthego's Cell Engineering Divisions to Boost CRISPR Market Innovations

EditCo Bio, Inc. announced that it has launched its business with the acquisition of Synthego's engineered cell solutions and enhanced guide RNA business. ...

 March 28, 2024 | News

Integrated DNA Technologies Launches Innovative Custom Vector Onboarding Tool to Streamline Gene Synthesis

Integrated DNA Technologies (IDT), a global leader in genomics solutions, announced  the expansion of its gene synthesis services with the launch of a...

 March 28, 2024 | News

Altamira Therapeutics Partners with Univercells to Enhance mRNA Vaccine Delivery

 Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (Nasdaq:CYTO), a company providing nanoparticle-based technology for...

 March 26, 2024 | News

Alphamab Oncology Launches Groundbreaking Clinical Trial in Australia for Advanced Cancer Treatment

Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been dosed in Australia in the clinical study (JSKN033-101) of JSKN0...

 March 26, 2024 | News

Sino Biological Announces Services Partnership with Rapid Novor

  This collaboration marks a significant stride in biotechnological services, covering major geographical regions including China, Singapore, Thailan...

 March 22, 2024 | News

European Commission Approves Bristol Myers Squibb’s Abecma as First Earlier-Line CAR T Therapy for Multiple Myeloma"

Bristol Myers Squibb announced a significant advancement in the treatment of multiple myeloma with the European Commission's approval of Abecma® (ideca...

 March 21, 2024 | News

Merck Invests Over €300 Million in New Daejeon Bioprocessing Center, Elevating Asia-Pacific's Biologics Sector and Generating 300 Jobs

Site to supply products to customers for development and production of biologics New Bioprocessing Production Center in Daejeon strengthens footprint of...

 March 20, 2024 | News

WuXi Biologics Breaks Ground on State-of-the-Art $1.4 Billion CRDMO Facility in Singapore

WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced ...

 March 19, 2024 | News

Thailand Welcomes Groundbreaking NanoString Center for Excellence in Genomic Research

NanoString Center for Excellence (COE) has officially opened its doors in Thailand, thanks to a pioneering partnership with Prima Scientific Co., Ltd. This...

 March 19, 2024 | News

BioGeometry and Sanyou Bio Announce Pioneering Alliance to Accelerate AI-Powered Antibody Research

BioGeometry, a frontrunner in digital biology and AI-driven protein design, alongside Sanyou Bio, a leading force in the high-tech biotechnology sector, ha...

 March 19, 2024 | News

SAMRC and Thermo Fisher Forge Partnership to Launch Molecular Biology Centre of Excellence in South Africa

The South African Medical Research Council (SAMRC) and Thermo Fisher Scientific Inc. have signed a Memorandum of Agreement (MOA) to collaborate on the esta...

 March 19, 2024 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close